Browse By Tags

PHILADELPHIA -- Novartis Pharmaceuticals Corp. will pay $422.5 million in criminal and civil penalties to resolve off-label marketing allegations for six drugs, the federal government announced Sept. 30 ( United States of America v. Novartis Pharmaceuticals...

PHILADELPHIA - (AP) Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced Thursday...